Versuchen GOLD - Frei
RIL looks for new energy catalyst
Mint Hyderabad
|July 21, 2025
In a spot
Reliance Industries Ltd's (RIL's) consolidated net profit (attributable to owners based on controlling interest) for the June quarter (Q1FY26) rose almost 20% year-on-year to ₹18,070 crore. This is even after excluding the gain realized on the sale of Asian Paints Ltd shares worth ₹8,924 crore.
While key oil-to-chemicals (O2C), retail and Jio telecom businesses have largely done well, the pressure on retail margin is evident.
Retail core EBITDA margin (excluding investment income) slid for the third consecutive quarter to 8.2% after hitting a peak of 8.5% in Q2FY25. With margin being almost flat year-on-year, absolute EBITDA increased 11% year-on-year to ₹6,044 crore, with similar growth in revenue to ₹73,720 crore.
Diese Geschichte stammt aus der July 21, 2025-Ausgabe von Mint Hyderabad.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Hyderabad
Mint Hyderabad
MakeMyTrip hiring banks for India IPO
MakeMyTrip Ltd, an online travel platform listed on the Nasdaq, is considering a listing in Mumbai, people familiar with the matter said.
1 min
April 30, 2026
Mint Hyderabad
Decoding Sebi’s broker net worth plan
The Securities and Exchange Board of India (Sebi) has proposed changes to the way variable net worth is calculated for stockbrokers.
2 mins
April 30, 2026
Mint Hyderabad
The 0.01 trap: India's GDP must not remain aloof from its people
We face a structural crisis in the collapse of formal job elasticity. Rapid economic growth must spell better lives for everyone
4 mins
April 30, 2026
Mint Hyderabad
Why rate cuts don't benefit every home loan borrower
Many lenders adjust loan tenure instead of EMIs, quietly increasing the total interest paid
4 mins
April 30, 2026
Mint Hyderabad
Piramal Pharma bets big on complex therapies
India’s Piramal Pharma hopes to accelerate earnings growth over the next two to three years, led by rising demand for complex drugs, including targeted cancer therapies, a top executive said on Wednesday.
1 min
April 30, 2026
Mint Hyderabad
Servify scouts for acquisitions ahead of filing for IPO
Smartphone care and warranty provider Servify is looking to close a string of acquisitions to expand its service categories before it files papers for a public listing.
1 mins
April 30, 2026
Mint Hyderabad
Vedanta FY26 earnings tops estimates ahead of its split
Vedanta reported FY26 revenue of ₹1.74 trillion, up 15.8% year-on-year, beating estimates
3 mins
April 30, 2026
Mint Hyderabad
Centre plans ring roads, elevated corridors to unclog urban India
The Union road transport and highways ministry is recalibrating its highbuilding strategy to focus on decongesting urban India, with plans to prioritize ring roads and bypass corridors around nearly 50 cities with populations exceeding one million, two people aware of the development said.
2 mins
April 30, 2026
Mint Hyderabad
Canada nod for DRL's GLP-1 shot
Dr Reddy's Laboratories (DRL) on Wednesday said it has received a notice of compliance (NoC) from Health Canada for its generic semaglutide injection indicated for the management of type-2 diabetes.
1 min
April 30, 2026
Mint Hyderabad
The UAE’s departure from OPEC may not break the cartel
WHEN THE Organisation of the Petroleum Exporting Countries (OPEC) meets on April 29th, the club will be contemplating the departure of one of its longest-standing members.
3 mins
April 30, 2026
Listen
Translate
Change font size

